Shangen Xu

621 total citations
18 papers, 466 citations indexed

About

Shangen Xu is a scholar working on Animal Science and Zoology, Infectious Diseases and Genetics. According to data from OpenAlex, Shangen Xu has authored 18 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Animal Science and Zoology, 10 papers in Infectious Diseases and 7 papers in Genetics. Recurrent topics in Shangen Xu's work include Animal Virus Infections Studies (12 papers), Viral gastroenteritis research and epidemiology (8 papers) and Virus-based gene therapy research (7 papers). Shangen Xu is often cited by papers focused on Animal Virus Infections Studies (12 papers), Viral gastroenteritis research and epidemiology (8 papers) and Virus-based gene therapy research (7 papers). Shangen Xu collaborates with scholars based in China, Malaysia and United States. Shangen Xu's co-authors include Liurong Fang, Shaobo Xiao, Dang Wang, Jiyao Chen, Xinyu Zhu, Jiahui Guo, Yanrong Zhou, Yimin Miao, Huanchun Chen and Yunbo Jiang and has published in prestigious journals such as Journal of Virology, The FASEB Journal and Journal of Controlled Release.

In The Last Decade

Shangen Xu

17 papers receiving 463 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shangen Xu China 11 326 307 191 80 78 18 466
Zhou Shen China 12 280 0.9× 206 0.7× 115 0.6× 62 0.8× 61 0.8× 35 440
Mingjun Su China 16 521 1.6× 570 1.9× 417 2.2× 24 0.3× 91 1.2× 28 699
Joeri Kint Netherlands 8 285 0.9× 214 0.7× 39 0.2× 89 1.1× 36 0.5× 10 377
Felicia P. Tay Singapore 11 337 1.0× 258 0.8× 60 0.3× 62 0.8× 46 0.6× 12 462
Pavita Kaewprommal Thailand 8 160 0.5× 185 0.6× 109 0.6× 18 0.2× 60 0.8× 16 275
Qianyue Jin China 11 149 0.5× 171 0.6× 131 0.7× 39 0.5× 60 0.8× 23 308
Tomoyoshi Doki Japan 14 376 1.2× 291 0.9× 240 1.3× 34 0.4× 20 0.3× 34 453
Honglei Zhang China 12 456 1.4× 479 1.6× 279 1.5× 35 0.4× 85 1.1× 21 695
Erzhen Duan China 10 143 0.4× 151 0.5× 97 0.5× 98 1.2× 107 1.4× 18 381
Kyung-il Kang United States 9 215 0.7× 180 0.6× 43 0.2× 82 1.0× 77 1.0× 14 355

Countries citing papers authored by Shangen Xu

Since Specialization
Citations

This map shows the geographic impact of Shangen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shangen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shangen Xu more than expected).

Fields of papers citing papers by Shangen Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shangen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shangen Xu. The network helps show where Shangen Xu may publish in the future.

Co-authorship network of co-authors of Shangen Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shangen Xu. A scholar is included among the top collaborators of Shangen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shangen Xu. Shangen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jin, Zheng, et al.. (2025). N-2-Hydroxypropyl Trimethyl Ammonium Chloride Chitosan-Aluminum Nano-Adjuvant Elicit Strong Immune Responses in Porcine Epidemic Diarrhea Inactivated Vaccine. International Journal of Nanomedicine. Volume 20. 1321–1334. 5 indexed citations
2.
Zhu, Rui, Hongyu Bao, Shangen Xu, et al.. (2025). Chitosan-based nanomaterials: Pioneering a review in veterinary medicine applications. International Journal of Biological Macromolecules. 320(Pt 4). 146011–146011.
3.
Xu, Shangen, Chenxi Sun, Yao Chen, et al.. (2025). Animal vaccine revolution: Nanoparticle adjuvants open the future of vaccinology. Journal of Controlled Release. 383. 113827–113827. 4 indexed citations
4.
Xu, Shangen, et al.. (2024). Immunoprotective effect of chitosan nanoparticles with different particle sizes against H9N2 avian influenza infection. Poultry Science. 104(1). 104559–104559. 3 indexed citations
5.
Xu, Shangen, Lu Yu, Qiaoyang Teng, et al.. (2023). Enhance immune response to H9 AIV DNA vaccine based on polygene expression and DGL nanoparticle encapsulation. Poultry Science. 102(10). 102925–102925. 8 indexed citations
6.
Xu, Shangen, Qiaoyang Teng, Xuesong Li, et al.. (2023). An immune-enhanced multivalent DNA nanovaccine to prevent H7 and H9 avian influenza virus in mice. International Journal of Biological Macromolecules. 251. 126286–126286. 6 indexed citations
7.
Chen, Jiyao, Zhuang Li, Jiahui Guo, et al.. (2022). SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog. Journal of Virology. 96(8). e0003722–e0003722. 35 indexed citations
9.
Guo, Jiahui, Zimin Liu, Zixin Wang, et al.. (2021). Evolutionary Dynamics of Type 2 Porcine Reproductive and Respiratory Syndrome Virus by Whole-Genome Analysis. Viruses. 13(12). 2469–2469. 25 indexed citations
10.
Xu, Ye, Xinyu Zhu, Jiahui Guo, et al.. (2020). Cross‐species transmission of deltacoronavirus and the origin of porcine deltacoronavirus. Evolutionary Applications. 13(9). 2246–2253. 29 indexed citations
11.
Zhu, Xinyu, Jiyao Chen, Yanrong Zhou, et al.. (2020). Porcine Deltacoronavirus nsp5 Cleaves DCP1A To Decrease Its Antiviral Activity. Journal of Virology. 94(15). 31 indexed citations
12.
Xu, Shangen, Yanrong Zhou, Zixin Wang, et al.. (2020). Characterization of Self-Processing Activities and Substrate Specificities of Porcine Torovirus 3C-Like Protease. Journal of Virology. 94(20). 5 indexed citations
13.
Zhou, Yanrong, Liurong Fang, Zhixiang Yang, et al.. (2019). Identification of novel proteolytically inactive mutations in coronavirus 3C‐like protease using a combined approach. The FASEB Journal. 33(12). 14575–14587. 46 indexed citations
14.
Wang, Dang, Jiyao Chen, Xinyu Zhu, et al.. (2019). Porcine Reproductive and Respiratory Syndrome Virus nsp11 Antagonizes Type I Interferon Signaling by Targeting IRF9. Journal of Virology. 93(15). 43 indexed citations
15.
Chen, Jiyao, Dang Wang, Li Gao, et al.. (2019). Arterivirus nsp4 Antagonizes Interferon Beta Production by Proteolytically Cleaving NEMO at Multiple Sites. Journal of Virology. 93(12). 33 indexed citations
16.
Guo, Jiahui, Liurong Fang, Jiyao Chen, et al.. (2018). Evolutionary and genotypic analyses of global porcine epidemic diarrhea virus strains. Transboundary and Emerging Diseases. 66(1). 111–118. 104 indexed citations
17.
Li, Dongge, Jing Wang, Shangen Xu, et al.. (2017). Identification and functional analysis of the novel ORF6 protein of porcine circovirus type 2 in vitro. Veterinary Research Communications. 42(1). 1–10. 35 indexed citations
18.
Dong, Jianming, Shangen Xu, Jing Wang, et al.. (2015). Porcine reproductive and respiratory syndrome virus 3C protease cleaves the mitochondrial antiviral signalling complex to antagonize IFN-β expression. Journal of General Virology. 96(10). 3049–3058. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026